Precigen (PGEN) Retained Earnings (2012 - 2026)
Precigen's (PGEN) quarterly Retained Earnings came in at -$17000.0 in Q1 2026, up 100.0% year-on-year from -$8500.0 in Q1 2025, and down 100.0% on a QoQ basis from $2.4 billion in Q4 2025.
Precigen (PGEN) Retained Earnings (2012 - 2026) Analysis & Trends
Precigen (PGEN) has 15 years of Retained Earnings data on file, last reported at -$17000.0 in Q1 2026.
- On a quarterly basis, Retained Earnings rose 100.0% year-over-year to -$17000.0 in Q1 2026; TTM through Mar 2026 was -$17000.0, a 100.0% increase from a year earlier, with the FY2025 full-year figure at $2.4 billion, up 19685333.33% from the prior year.
- Retained Earnings for Q1 2026 stood at -$17000.0, down from $2.4 billion in the prior quarter.
- Over the last five years, Retained Earnings for PGEN reached as high as $2.4 billion in Q4 2025 and fell as low as -$2.1 billion in Q1 2025.
- Historically, Retained Earnings has averaged $410.3 million across 5 years, with a median of -$17000.0 in 2026.
- Across the five-year window, Retained Earnings plunged 73564.65% in 2024 and surged 19685333.33% in 2025, its largest moves.
- Year by year, Retained Earnings stood at -$3.5 million in 2022, then jumped by 59873.97% to $2.1 billion in 2023, then tumbled by 100.0% to $12000.0 in 2024, then jumped by 19685333.33% to $2.4 billion in 2025, then plunged by 100.0% to -$17000.0 in 2026.
- Per Business Quant data, the three most recent Retained Earnings figures were -$17000.0 in Q1 2026, $2.4 billion in Q4 2025, and $2.4 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Precigen | 1.96 Bn | 1.96 Bn | 20.69 Mn | -17,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17,000.00 |
| Dec 31, 2025 | 2.36 Bn |
| Sep 30, 2025 | 2.36 Bn |
| Jun 30, 2025 | 2.13 Bn |
| Mar 31, 2025 | -2.14 Bn |
| Dec 31, 2024 | 12,000.00 |
| Sep 30, 2024 | -2.07 Bn |
| Jun 30, 2024 | 2.09 Bn |
| Mar 31, 2024 | -1.99 Bn |
| Dec 31, 2023 | 2.08 Bn |
| Sep 30, 2023 | 2.08 Bn |
| Jun 30, 2023 | -1.91 Bn |
| Mar 31, 2023 | -2.70 Mn |
| Dec 31, 2022 | -3.49 Mn |
| Sep 30, 2022 | -7.18 Mn |
| Jun 30, 2022 | -4.56 Mn |
| Mar 31, 2022 | 1.99 Bn |
| Dec 31, 2021 | -1.92 Bn |
| Sep 30, 2021 | 1.52 Mn |
| Jun 30, 2021 | 2.02 Bn |